SPOTLIGHT -
Unmet Needs and Future Perspectives in the NSCLC Treatment Landscape
Looking to the future, a panel of experts offer closing remarks on promising developments and unmet needs in the treatment of NSCLC.
Read More
Neoadjuvant Therapy and Other Emerging Therapies in Early Stage NSCLC
Experts discuss the role of neoadjuvant therapy and other emerging therapies in the treatment of early-stage NSCLC.
Treatment Approach for Patients With Stage II-IIIA NSCLC
Jaspal Singh, MD, MHS, shares insights on treatment strategies for patients with stage II-IIIA NSCLC.
Patient Profile 2: Former Smoker Diagnosed With NSCLC
David H. Harpole Jr, MD, presents a case of a former smoker diagnosed with NSCLC, and David Spigel, MD, offers his initial impressions.
Choosing Appropriate Patients for Surgical Resection in NSCLC
An expert panel shares perspectives on how to choose the appropriate patients with non-small cell lung cancer for lung resection.
Therapies Targeting Specific Molecular Alterations in NSCLC
A panel of distinguished experts discuss how detection of actionable mutations affect their treatment choices in non-small cell lung cancer.
Adjuvant Therapy in Early Stage NSCLC
David Spigel, MD, and David H. Harpole Jr, MD, describe when adjuvant therapy is recommended in early stage NSCLC and discuss data from recent clinical trials of adjuvant therapy.
Treatment Approach for Patients With Stage IB Disease
A panel of experts in the treatment of NSCLC discusses how they manage patients with stage IB disease.
Workup and Molecular Testing for a Patient with NSCLC
David H. Harpole Jr, MD, a thoracic surgeon, details his workup approach and discussed molecular testing for patients who present with NSCLC.
Patient Profile 1: A 57-Year-Old Woman Diagnosed With NSCLC
David Spigel, MD, presents a patient case of a 57-year-old woman with NSCLC, and Jaspal Singh, MD, MHS, discusses his approach to initial evaluation.
Multidisciplinary Care in Non-Small Cell Lung Cancer
A panel of experts introduce themselves and explain their approaches to multidisciplinary care in treating non-small cell lung cancer.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
